Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 1702Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1High Rate of Awarding Compensation for Claims of Injuries Related to Clinical Trials by Pharmaceutical Companies in Japan: A Questionnaire Survey
Chieko Kurihara,Hideo Kusuoka,Shunsuke Ono,Naoko Kakee,Kazuyuki Saito,Kenji Takehara,Kiyokazu Tsujide,Yuzo Nabeoka,Takuya Sakuhiro,Hiroshi Aoki,Noriko Morishita,Chieko Suzuki,Shigeo Kachi,Emiko Kondo,Yukiko Komori,Tetsu Isobe,Shigeru Kageyama,Hiroshi Watanabe,David Joseph Diemert
PLoS ONE.2014;9(1)e84998
[DOI]
2Capacity for ethical and regulatory review of herbal trials in developing countries: a case study of Moringa oleifera research in HIV-infected patients
Tsitsi G. Monera-Penduka,Charles C. Maponga,Gene D. Morse,Charles F. B. Nhachi
Journal of Pharmaceutical Policy and Practice.2017;10(1)e84998
[DOI]
3The revised Declaration of Helsinki: cosmetic or real change?
Aisha Y Malik,Charles Foster
Journal of the Royal Society of Medicine.2016;109(5)184
[DOI]
4Compensation for Clinical Trial-Related Injury and Death in India: Challenges and the Way Forward
Yogendra Kumar Gupta,Arun Kumar Pradhan,Aman Goyal,Prafull Mohan
Drug Safety.2014;37(12)995
[DOI]
5Appropriateness of no-fault compensation for research-related injuries from an African perspective: an appeal for action by African countries: Table1
Patrick Dongosolo Kamalo,Lucinda Manda-Taylor,Stuart Rennie
Journal of Medical Ethics.2016;42(8)528
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal